HCPLive Network

Current Pain Assessment Tools for Geriatric Patients Missing from Practices

Although many reliable and valid pain assessment tools for cognitively intact and impaired geriatric patients are currently available, clinical evidence emphasized by Keela Herr, PhD, RN, FAAN, AGSF, co-director of the John A. Hartford Center for Geriatric Nursing Excellence at the University of Iowa College of Nursing, suggests those scales are not consistently administered throughout practice settings.

At a plenary session of the American Pain Society’s 32nd Annual Scientific Meeting, held May 8-13, 2013, in New Orleans, LA, Herr said one study found 95 percent of geriatric hospital patients experiencing pain received no objective pain assessment based on a valid tool during initial assessment from a doctor. In the hospice setting, initial assessment was sound, but reassessment — which Herr said is crucial to monitoring a treatment’s effectiveness — was extremely low.

Additionally, a study by Elizabeth Manias of the University of Melbourne School of Health Sciences found that a group of nurses were applying the same strategies they used throughout their careers to all geriatric pain patients, rather than individualizing care with available tailored pain scales, while another study by Andrea Gilmore, RN, of the University of Wisconsin-Madison School of Nursing, conducted qualitative interviews of 13 nurses across four nursing homes and discovered that they lacked clear procedures for assessing pain.

But Herr said issues surrounding pain assessment in older adults also stem from the sheer number of tools available and the variability among them, as she noted “there are now over 35 non-verbal pain tools available across the world — ranging from five behavioral categories to 60 individual behaviors and from presence of pain to pain intensity — and there’s no single best tool for practices to use.”


Further Reading
According to the Administration on Aging, patients older than 65 are expected to account for approximately 19 percent of the U.S. population by 2030, compared to 12.9 percent today.
Analysis of claims data finds patients often receive starting doses of Butrans that do not follow published recommendations, with more than one-third of patients receiving initial doses that are too low.
Though the total National Institutes of Health (NIH) budget has stayed flat over the past several years, chronic pain research has enjoyed an expanded slice of the federal funding pie, as dollars committed to that portion of science grew from $279 million in 2008 to $396 million in 2012.
More Reading
$related2$
$AD300x250BB$